Characterization of Selective and Potent PI3Kδ Inhibitor (PI3KD-IN-015) for B-Cell Malignances

Mar 21,2017|By Liu X, Wang A, Liang X, Chen C, Liu J, Zhao Z, Wu H, Deng Y, Wang L, Wang B, Wu J, Liu F, Fernandes SM, Adamia S, Stone RM, Galinsky IA, Brown JR, Griffin JD, Zhang S, Loh T, Zhang X, Wang W, Weisberg EL, Liu J, Liu Q. DOI: 10.18632/oncotarget.8702